Literature DB >> 21816136

The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome.

Gürdal Yilmaz1, Iftihar Köksal, S Caner Karahan, Ahmet Mentese.   

Abstract

OBJECTIVES: This study was intended to investigate the value of suPAR, C-reactive protein (CRP) and procalcitonin (PCT) in the determination and prognosis of systemic inflammatory response syndrome (SIRS) patients.
METHODS: The study was performed among patients with at least two SIRS criteria. PCT, CRP and suPAR were analyzed from the blood specimens taken.
RESULTS: Eighty-five patients were enrolled in the SIRS group (44 bacteremia, 20 urinary tract infection, 12 pneumonia and 9 non-infection), and 53 individuals in the control group. A significant correlation was determined between suPAR, PCT and CRP values in both groups (P<0.0001). A suPAR cutoff value of 2.8ng/mL was associated with an NPV of 87% and PPV of 91%, with 92% sensitivity and 85% specificity. A relatively high suPAR level that might predict fatality was also determined in fatal cases (P=0.001).
CONCLUSION: suPAR possesses high sensitivity and specificity levels in terms of differential diagnosis, and high suPAR levels can predict fatality.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816136     DOI: 10.1016/j.clinbiochem.2011.07.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  21 in total

1.  Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia.

Authors:  Hong Guo; Lan-Xia Zhou; Haizhen Ma; Bei Liu; Juan Cheng; Yun-Yun Ma; Li Zhao
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

2.  Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis.

Authors:  Emel Okulu; Saadet Arsan; Ilke Mungan Akin; Can Ates; Serdar Alan; Atila Kilic; Begum Atasay
Journal:  J Clin Lab Anal       Date:  2014-07-10       Impact factor: 2.352

3.  Clinical significance of serum and urinary soluble urokinase receptor (suPAR) in primary nephrotic syndrome and MPO-ANCA-associated glomerulonephritis in Japanese.

Authors:  Keiji Fujimoto; Junko Imura; Hirokatsu Atsumi; Yuki Matsui; Hiroki Adachi; Hiroshi Okuyama; Hideki Yamaya; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2014-12-13       Impact factor: 2.801

4.  Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Authors:  Carlos R Franco Palacios; John C Lieske; Hani M Wadei; Andrew D Rule; Fernando C Fervenza; Nikolay Voskoboev; Vesna D Garovic; Ladan Zand; Mark D Stegall; Fernando G Cosio; Hatem Amer
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

5.  Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer.

Authors:  Evren Fidan; Ahmet Mentese; Feyyaz Ozdemir; Orhan Deger; Halil Kavgaci; S Caner Karahan; Fazil Aydin
Journal:  Med Oncol       Date:  2013-03-20       Impact factor: 3.064

6.  Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.

Authors:  B Suberviola; A Castellanos-Ortega; A Ruiz Ruiz; M Lopez-Hoyos; M Santibañez
Journal:  Intensive Care Med       Date:  2013-08-16       Impact factor: 17.440

7.  Circulating suPAR in two cohorts of primary FSGS.

Authors:  Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

8.  Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis.

Authors:  Pingping Sun; Lei Yu; Jing Huang; Suxia Wang; Wanzhong Zou; Li Yang; Gang Liu
Journal:  Kidney Dis (Basel)       Date:  2019-05-27

9.  Why high suPAR is not super--diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU.

Authors:  Alexander Koch; Frank Tacke
Journal:  Crit Care       Date:  2011-12-15       Impact factor: 9.097

10.  Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels.

Authors:  Anna Gustafsson; Vjosa Ajeti; Lennart Ljunggren
Journal:  Biomark Insights       Date:  2011-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.